Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Marrone Bio Innov (MBII)

Marrone Bio Innov (MBII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 306,787
  • Shares Outstanding, K 175,307
  • Annual Sales, $ 38,370 K
  • Annual Income, $ -20,170 K
  • 60-Month Beta 0.16
  • Price/Sales 8.09
  • Price/Cash Flow N/A
  • Price/Book 8.78
Trade MBII with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.00
  • Low Estimate -0.01
  • Prior Year -0.02
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3300 +32.33%
on 06/03/21
1.9479 -9.65%
on 06/14/21
+0.2500 (+16.56%)
since 05/18/21
3-Month
1.3200 +33.33%
on 05/13/21
2.4873 -29.24%
on 03/24/21
-0.5900 (-25.11%)
since 03/18/21
52-Week
0.9900 +77.78%
on 06/24/20
2.9000 -39.31%
on 02/09/21
+0.6700 (+61.47%)
since 06/18/20

Most Recent Stories

More News
180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors

180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases,...

ATNF : 10.27 (-1.72%)
MBII : 1.7600 (+0.57%)
TRTC : 0.3255 (+1.72%)
Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus(R) Biofungicide in Canada

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI or "Marrone Bio"), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, has entered into...

MBII : 1.7600 (+0.57%)
Thinking about buying stock in Marrone Bio Innovations, Village Farms, Moxian, Lucira Health, or Kadmon Holdings?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBII, VFF, MOXC, LHDX, and KDMN.

KDMN : 3.99 (-4.55%)
LHDX : 4.85 (+0.83%)
VFF : 9.99 (-4.95%)
MBII : 1.7600 (+0.57%)
MOXC : 11.62 (-1.44%)
Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Misses Revenue Estimates

Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0.00% and -0.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?...

MBII : 1.7600 (+0.57%)
Marrone Bio Innovations Issues Shareholder Letter

Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released...

MBII : 1.7600 (+0.57%)
Marrone Bio Innovations, Inc. Reports First-Quarter 2021 Financial Results

Marrone Bio Innovations, Inc. (NASDAQ: MBII) has provided its financial results for the first quarter ended March 31, 2021. Key results include:

MBII : 1.7600 (+0.57%)
Marrone Bio Innovations, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Marrone Bio Innovations, Inc. (NASDAQ:MBII) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at...

MBII : 1.7600 (+0.57%)
Biostimulants Market to Reach USD 5.35 Billion By 2027; Increasing Demand for Organic Products Globally to Stimulate Growth, Says Fortune Business Insights(TM)

The global biostimulants market size is expected to gain traction by reaching USD 5.35 billion by 2027. This information is published by Fortune Business Insights in its report, titled "Biostimulants Market,...

BASFY : 19.1800 (-3.03%)
MBII : 1.7600 (+0.57%)
SYT : 92.90 (unch)
Will Marrone Bio Innovations, Inc. (MBII) Report Negative Earnings Next Week? What You Should Know

Marrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MBII : 1.7600 (+0.57%)
BIOSt(R) Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pesticides

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable agricultural biological solutions, announced today that BIOSt Nematicide seed treatment product, achieved an outstanding...

MBII : 1.7600 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production,...

See More

Key Turning Points

3rd Resistance Point 1.8933
2nd Resistance Point 1.8567
1st Resistance Point 1.8033
Last Price 1.7600
1st Support Level 1.7133
2nd Support Level 1.6767
3rd Support Level 1.6233

See More

52-Week High 2.9000
Fibonacci 61.8% 2.1704
Fibonacci 50% 1.9450
Last Price 1.7600
Fibonacci 38.2% 1.7196
52-Week Low 0.9900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar